HopeStage
Back to all studies
TerminatedNCT00054704

Riluzole to Treat Depression in Bipolarity

Researchers are comparing Riluzole and placebo to find out how the approaches affect depression symptoms in people with bipolarity during a depressive episode.

Medication studyAges 18–70United States
The study in practice

Understand this study

What is this study about?

Researchers are comparing Riluzole and placebo to find out how the approaches affect depression symptoms in people with bipolarity during a depressive episode.

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2003
Recruitment status
Terminated
Enrollment listed in the registry
19
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00054704
Official title
Show the full official title

An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

Recruitment & locations

Terminated

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing Riluzole and placebo to find out how the approaches affect depression symptoms in people with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Does this study involve medication?

Yes. The study involves medication, including Riluzole and Placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies